Nuclear Medicine and Molecular Imaging is a medical discipline that is differentially characterized by the use of radioactive substances or radiopharmaceuticals for diagnosis and management of diseases in line with advancements emerging in the world of medicine. The Nuclear Medicine and Molecular Imaging Center at the American Hospital combats diseases in this field with the combination of highly experienced medical professionals and cutting-edge technology. Our center’s primary principle is to supplement healthcare services by establishing and cultivating the most advanced healthcare technologies and facilities with a high level of skill, as well as authentic empathy.

The Radio-pharmacy laboratory that has been established and developed at the American Hospital, is operated in line with the globally acknowledged cGMP (Current Good Manufacturing Practices) standards as well as national and international accreditations.

Personalized procedures that are available at our Targeted Radionuclide Therapy Clinic showcase our hospital’s quality in diversity. Renoprotective methods are employed to protect kidneys in groups of special patients and the dosimeter minimizes the radiation dose delivered to healthy tissues.

To provide truly world-class services to our patients, the Nuclear Medicine and Imaging Center at the American Hospital combines knowledge gleaned from observations of forefront global developments in the world of medicine with the continuous provision of good quality health care, expertise in this specific field as well as crucial experience.
-2..Kat -2.Floor
08:00 - 17:00 08:00 - 17:00
Monday - Friday Monday - Friday


Nuclear Medicine and Molecular Imaging helps other departments to reveal underlying causes of medical problems based on functional data taken from organs and bones. Therefore,

  • Benign and malignant tumors
  • Different varieties of cancer
  • Bones
  • Brain
  • Endocrine disorders
  • Gallbladder
  • Cardiovascular disease
  • Lung diseases
  • Lymphoma,
  • Neuroblastoma
  • Neuroendocrine tumors
  • Pediatric diseases
  • Prostate cancer
  • Kidney
Thyroid diseases (thyroid cancer, Graves’ disease) and relevant complaints are the reasons for admission
For oncology patients, Nuclear Medicine and Molecular Imaging is required to differentiate benign lesions from malignant tumors, to determine stage of cancer, to determine the grade of each tumor and its invasion into organs, to investigate metastasis, detect relapse, choose treatment option, to evaluate response to the treatment (chemo- or radio-sensitivity), to locate the primary tumor and to deliver the accurate dose to the correct body part.

Our clinic treats thyroid cancer, prostate cancer, neuroendocrine tumor, neuroblastoma, primary or metastatic liver tumors and some forms of lymphoma and provides palliative therapy for bone metastases along with radionuclide therapies.

Intraoperative Gamma Probe is applied to manage head & neck tumors and urogenital tumors, although predominately breast cancer and malignant melanoma are exposed. After the sentinel lymph node that is fed by cancer tissue is marked with a radioactive substance, it is possible to expose and excise this node with a probe system during surgery.
  • PET (Positron Emission Tomography) and CT (Computerized Tomography) for diagnosis
  • Scintigraphic (SPECT/CT, SPECT scans)
  • Bone densitometry (DEXA)
  • Urea breath test
  • Intraoperative Gamma Probe
  • Labeled WBC scintigraphy
  • Radioiodine (low-dose and high-dose)
  • 177Lu-PSMA (Lutetium - 177 prostate-specific membrane antigen)
  • Lutetium 177 peptide receptor
  • Actinium-225
  • Radium-223
  • I-131 MIBG (radiopharmaceutical used for both imaging and treating certain types of neuroendocrine tumors)
  • Radioimmunoassay (RIA) Laboratory (where autoantibody, hormone and tumor markers in human serum are analyzed with specific methods)
  • Radiopharmacy laboratory (where multiple molecules are prepped for imaging and treatment) can be listed as sub-services and methods we provide.